Document:

Non-Employee Director Compensation Policy

 Exhibit 10.9 

INSTRUCTURE, INC. 

NON-EMPLOYEE DIRECTOR COMPENSATION POLICY 

APPROVED BY THE BOARD OF DIRECTORS 

JUNE 18, 2015 

Each member of the Board of Directors (the “Board”) who is not also serving as an employee of Instructure, Inc.
(“Instructure”) or any of its subsidiaries (each such member, an “Eligible Director”) will receive the compensation described in this Non-Employee Director Compensation Policy (the
“Policy”) for his or her Board service following the initial public offering of the common stock of Instructure (the “IPO”). 

This Policy will be effective upon the execution and delivery of the underwriting agreement between Instructure and the underwriters managing
the IPO (the “IPO Date”). This Policy may be amended at any time in the sole discretion of the Board. 
 Annual Cash Compensation

 Commencing on the IPO Date, each Eligible Director will be entitled receive the cash compensation described below. The annual cash
compensation amount set forth below is payable in equal quarterly installments, payable in arrears on the last day of each fiscal quarter in which the service occurred. If an Eligible Director joins the Board or a committee of the Board (a
“Committee”) at a time other than effective as of the first day of a fiscal quarter, each annual retainer set forth below will be pro-rated based on days served in the applicable fiscal year, with the pro-rated amount paid
for the first fiscal quarter in which the Eligible Director provides the service, and regular full quarterly payments thereafter. All annual cash retainer fees are vested upon payment. 

Annual Board Service Retainer 
  

	 	•	 	Eligible Directors: $30,000 

 Annual Committee Chair Service Retainer1 
  

	 	•	 	Chairperson of the Audit Committee: $20,000 

  

	 	•	 	Chairperson of the Compensation Committee: $10,000 

  

	 	•	 	Chairperson of the Nominating & Corporate Governance Committee: $7,500 

 Annual Committee Member
Service Retainer 
  

	 	•	 	Member of the Audit Committee: $7,500 

  

	 	•	 	Member of the Compensation Committee: $5,000 

  

	 	•	 	Member of the Nominating & Corporate Governance Committee: $3,500 

  

	1 	Eligible Directors who serve as a Committee Chair will not receive the annual retainer for service as a member on such Committee. 

 Equity Compensation 

Commencing on the IPO Date, each Eligible Director will be eligible to receive the equity compensation described below. All equity compensation
will be granted under the Instructure, Inc. 2015 Equity Incentive Plan (the “Plan”), and will be documented on the applicable form of equity award agreement most recently approved for use by the Board (or a duly authorized
committee thereof) for Eligible Directors. Capitalized terms not explicitly defined in this Policy but defined in the Plan will have the same definitions as in the Plan. 

IPO Grant 
 On the IPO Date,
certain of the Eligible Directors designated by the Board will be granted restricted stock units (“RSUs”) with an RSU Value (as defined below) of up to $350,000 (the “IPO RSU Grant”). The IPO RSU Grant
will vest annually with (i) up to 50% vesting on the last market trading day immediately prior to the first Instructure annual stockholder meeting held after the IPO Date and (ii) the remainder vesting on the last market trading day
immediately prior to the second Instructure annual stockholder meeting held after the IPO Date, subject in each case to the Eligible Director’s Continuous Service on such vesting date. 

Initial Grant 
 On the date of an
Eligible Director’s initial appointment to the Board (or, if such date is not a market trading day, the first market trading day thereafter), the Eligible Director automatically will be granted, without further action by the Board, RSUs with an
RSU Value of (the “Initial Appointment RSU Grant”): 
  

	 	(i)	$175,000, multiplied by a fraction, the numerator of which is 365 less the number of days that have elapsed since the date of Instructure’s last annual stockholder meeting (or if an annual stockholder meeting has
yet to be held, then the IPO Date) and the Eligible Director’s date of initial appointment or election, and the denominator of which is 365 (the “Pro-rated Portion”) plus 

 

	 	(ii)	$175,000 (the “Annual Portion”). 

 The Initial Appointment RSU grant
shall vest annually with (a) the Pro-rated Portion of the Initial Appointment RSU vesting on the last market trading day immediately prior to the date of the first Instructure annual stockholder meeting following such appointment and
(b) the Annual Portion of the Initial Appointment RSU vesting on the last market trading day immediately prior to the date of the second Instructure annual stockholder meeting following such appointment, subject in each case to the Eligible
Director’s Continuous Service on the applicable vesting date. 
 If an Eligible Director is initially elected at an annual meeting of
stockholders rather than appointed, the Eligible Director automatically will be granted on such date, without further action by the Board, RSUs with an RSU Value of $350,000 (each an “Initial Election RSU Grant”). The Initial
Election RSU Grant will vest annually with (i) 50% vesting on the last market trading day immediately prior to the date of the next Instructure annual stockholder meeting and (ii) 50% vesting on the last market trading day immediately
prior to the date of the second Instructure annual stockholder meeting following such election, subject in each case to the Eligible Director’s Continuous Service on the applicable vesting date. 

  
 2. 

 Biennial Grant 

On the date of each Instructure annual stockholder meeting held after the IPO Date, each Eligible Director (i) who is then continuing in
office after the date of the Annual Meeting (and who, for the avoidance of doubt, is not elected for the first time to be a member of the Board at such annual stockholder meeting) and (ii) whose IPO RSU Grant, Initial Appointment RSU Grant,
Initial Election RSU Grant or most recent Biennial RSU Grant, as applicable, has fully vested on the last market trading day immediately prior to the date of such annual stockholder meeting automatically, and without further action by the Board,
will be granted RSUs with an RSU Value of $350,000 (the “Biennial RSU Grant”). The Biennial RSU Grant will vest annually with (i) 50% vesting on the last market trading day immediately prior to the date of the next
Instructure annual stockholder meeting and (ii) 50% vesting on the last market trading day immediately prior to the date of the following Instructure annual stockholder meeting, subject in each case to the Eligible Director’s Continuous
Service on the applicable vesting date. 
 Calculation of RSU Value 

The “RSU Value” of an RSU award to be granted under this Policy will be determined based on the Fair Market Value per
share on the applicable grant date; provided however, that for purposes of the IPO RSU Grant, the Fair Market Value will be the price per share to the public in the IPO (as specified in the final prospectus for the IPO). 

Change in Control or Corporate Transaction 

In the event of a Change in Control or a Corporate Transaction, any unvested portion of any RSU award granted pursuant to this Policy will
fully vest as of immediately prior to the effective time of such Change in Control or Corporate Transaction, subject to the Eligible Director’s Continuous Service on the effective date of such transaction. 

Election to Receive Annual Cash Compensation in the Form of RSUs 

Each Eligible Director may elect, in writing, to receive his or her annual cash compensation in the form of RSUs. Such election would apply to
all annual cash compensation payable during the subsequent year of service. If elected, RSUs will be granted under the Plan and will be documented on the applicable form of equity award agreement most recently approved for use by the Board (or a
duly authorized committee thereof) for Eligible Directors. All RSUs under this paragraph will be granted on the date of the Instructure annual stockholder meeting, and will vest in full on the last market trading day immediately prior to the date of
the next Instructure annual stockholder meeting, subject to the Eligible Director’s Continuous Service on the applicable vesting date. 

The number of shares of common stock that an Eligible Director will receive as an RSU in lieu of such annual cash compensation will be
determined by dividing (i) the amount of annual cash compensation that would otherwise be paid during the upcoming year of service, by (ii) the Fair Market Value of a share of common stock on the applicable grant date. Any election to
receive an RSU in lieu of annual cash compensation must be made by the Eligible Director at least five (5) business days prior to the date of the applicable Instructure annual stockholder meeting and such election will be irrevocable until the
next Instructure annual stockholder meeting. 
 Expenses 

The Company will reimburse Eligible Directors for ordinary, necessary and reasonable out-of-pocket travel expenses to cover in-person
attendance at and participation in Board and/or Committee 

  
 3. 

 
meetings; provided, that Eligible Directors timely submit to the Company appropriate documentation substantiating such expenses in accordance with the Company’s travel and expense
policy, as in effect from time to time. 
 Philosophy 

This Policy is designed to attract and retain experienced, talented individuals to serve on the Board. The Compensation Committee of the Board
shall periodically review and recommend to the Board the type and amount of compensation to be paid or awarded to Board members, including any consulting, retainer, Board meeting, committee and committee chair fees and equity awards. The
Compensation Committee may invite the Company’s Chief Executive Officer to be present during these deliberations. This Policy, as amended from time to time, may take into account the time commitment expected of Eligible Directors, best
practices and market rates in director compensation, the economic position of Instructure, broader economic conditions, historical compensation structure, the advice of the compensation consultant that the Compensation Committee or the Board may
retain from time to time, and the potential dilutive effect of equity awards on our stockholders. 
 Under this Policy, Eligible Directors
receive cash compensation in the form of retainers to recognize their level of responsibility as well as the necessary time commitment involved in serving in a leadership role and/or on Committees. Eligible Directors also receive equity compensation
because we believe that stock ownership provides an incentive to act in ways that maximize long-term stockholder value. Further, we believe that stock-based awards are essential to attracting and retaining talented Board members. We believe that the
vesting acceleration provided in the case of a Change in Control or other Corporate Transaction is consistent with market practices and is critical to attracting and retaining high quality directors. 

  
 4.EX-4.01

 Exhibit 4.01 

ADESTO TECHNOLOGIES CORPORATION 

FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

 TABLE OF CONTENTS 
  

									
	 	 	 	  	 	  	Page	 
	 1.
	 	 Definitions
	  	 	2	  
			
	 2.
	 	 Registration Rights
	  	 	5	  
				
		 	 2.1.
	  	 Request for Registration
	  	 	5	  
				
		 	 2.2.
	  	 Company Registration
	  	 	8	  
				
		 	 2.3.
	  	 Obligations of the Company
	  	 	8	  
				
		 	 2.4.
	  	 Furnish Information
	  	 	10	  
				
		 	 2.5.
	  	 Expenses of Demand Registration
	  	 	10	  
				
		 	 2.6.
	  	 Expenses of Company Registration
	  	 	10	  
				
		 	 2.7.
	  	 Underwriting Requirements
	  	 	10	  
				
		 	 2.8.
	  	 Delay of Registration
	  	 	11	  
				
		 	 2.9.
	  	 Indemnification
	  	 	11	  
				
		 	 2.10.
	  	 Reports Under Exchange Act
	  	 	13	  
				
		 	 2.11.
	  	 Form S-3 Registration
	  	 	14	  
				
		 	 2.12.
	  	 Assignment of Registration Rights
	  	 	15	  
				
		 	 2.13.
	  	 Limitations on Subsequent Registration Rights
	  	 	16	  
				
		 	 2.14.
	  	 “Market Stand-Off” Agreement
	  	 	16	  
				
		 	 2.15.
	  	 Termination of Registration Rights
	  	 	17	  
			
	 3.
	 	 Information, Observer and Inspection Rights
	  	 	17	  
				
		 	 3.1.
	  	 Delivery of Financial Statements
	  	 	17	  
				
		 	 3.2.
	  	 Inspection
	  	 	19	  
				
		 	 3.3.
	  	 Assignment
	  	 	19	  
				
		 	 3.4.
	  	 Termination of Information and Inspection Covenants
	  	 	19	  
				
		 	 3.5.
	  	 Confidentiality
	  	 	19	  
			
	 4.
	 	 Right of First Offer
	  	 	20	  
				
		 	 4.1.
	  	 Right of First Offer
	  	 	20	  
				
		 	 4.2.
	  	 Termination
	  	 	21	  
			
	 5.
	 	 Additional Covenants
	  	 	21	  
				
		 	 5.1.
	  	 Insurance
	  	 	21	  
				
		 	 5.2.
	  	 Employee Agreements
	  	 	21	  
				
		 	 5.3.
	  	 Employee Vesting
	  	 	22	  

											
					
					 5.4.
		 Employment Agreement
		 	20	  
					
					 5.5
		 Milestone Achievement
		 	20	  
					
					 5.6
		 Technology License Option
		 	20	  
					
					 5.7
		 Right to Participate
		 	20	  
					
					 5.8
		 Termination of Covenants
		 	23	  
				
			 6.
		 Miscellaneous
		 	24	  
					
					 6.1.
		 Transfers, Successors and Assigns
		 	24	  
					
					 6.2.
		 Governing Law
		 	24	  
					
					 6.3.
		 Counterparts
		 	24	  
					
					 6.4.
		 Titles and Subtitles
		 	24	  
					
					 6.5.
		 Notices
		 	24	  
					
					 6.6.
		 Costs of Enforcement
		 	24	  
					
					 6.7.
		 Amendments and Waivers
		 	24	  
					
					 6.8.
		 Severability
		 	25	  
					
					 6.9.
		 Aggregation of Stock
		 	25	  
					
					 6.10.
		 Entire Agreement
		 	25	  
					
					 6.11.
		 Transfers of Rights
		 	25	  
					
					 6.12.
		 Dispute Resolution
		 	26	  
					
					 6.13.
		 Delays or Omissions
		 	26	  
					
					 6.14.
		 Further Assurances
		 	26	  
		
	 Schedule A
		 -            Schedule of Investors
	   

 ADESTO TECHNOLOGIES CORPORATION 

FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

THIS FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”) is made as of the 19th day of August 2013 by and among Adesto Technologies Corporation, a California corporation (the “Company”), and each of the investors listed on Schedule A hereto (each,
an “Investor,” and collectively, the “Investors”). 
 RECITALS 

WHEREAS, certain of the Investors are holders of outstanding shares of the Company’s Series A Preferred Stock (the
“Series A Preferred Stock”) issued by the Company pursuant to that certain Series A Preferred Stock Purchase Agreement dated as of February 21, 2007 (the “Prior Series A Investors”); 

WHEREAS, certain of the Investors are holders of outstanding shares of the Company’s Series B Preferred Stock (the
“Series B Preferred Stock”) issued by the Company pursuant to that certain Series B Preferred Stock Purchase Agreement dated as of August 19, 2009 and that certain Series B Preferred Stock Purchase Agreement dated as
of May 27, 2010 (the “Prior Series B Investors”); 
 WHEREAS, certain of the Investors are holders of
outstanding shares of the Company’s Series C Preferred Stock (the “Series C Preferred Stock”) issued by the Company pursuant to that certain Series C Preferred Stock Purchase Agreement dated as of July 6,
2011 (the “Prior Series C Investors” and, together with the Prior Series B Investors and the Prior Series A Investors, the “Prior Investors”); 

WHEREAS, certain of the Investors are holders of outstanding shares of the Company’s Series D Preferred Stock (the
“Series D Preferred Stock”) issued by the Company pursuant to that certain Series D Preferred Stock Purchase Agreement dated as of August 8, 2012 (the “Prior Series D Investors” and, together with the
Prior Series C Investors, the Prior Series B Investors and the Prior Series A Investors, the “Prior Investors”); 

WHEREAS, the Prior Investors have been granted certain rights to cause the Company to register shares of its Common Stock issuable to
the Prior Investors, to receive certain information from the Company, to participate in future equity offerings by the Company and certain other matters pursuant to that certain Third Amended and Restated Investors’ Rights Agreement by and
among the Company and the Prior Investors dated as of August 8, 2013 (the “Prior Agreement”); 
 WHEREAS, the
Company and certain of the Investors (the “New Investors”) are parties to that certain Series E Preferred Stock Purchase Agreement dated as of even date herewith, as such may be amended from time to time (the “Series E
Purchase Agreement”), pursuant to which such Investors are purchasing shares of Series E Preferred Stock of the Company (the “Series E Preferred Stock”) and converting outstanding promissory notes issued by the Company
into shares of Series D-1 Preferred Stock of the Company (the “Series D-1 Preferred Stock” and, together with the Series A Preferred Stock, the Series B Preferred Stock, the Series C Preferred Stock, the Series D Preferred Stock and
the Series E Preferred Stock, the “Preferred Stock”); 

 WHEREAS, the obligations of the Company and the New Investors under the Series E Purchase
Agreement are conditioned, among other things, upon the execution and delivery of this Agreement by the Investors and the Company, and the Prior Investors and the Company desire to amend, restate and replace their rights and obligations under the
Prior Agreement with the rights and obligations set forth in this Agreement. 
 NOW, THEREFORE, THE PARTIES HEREBY AGREE AS
FOLLOWS: 
 1. Definitions. For purposes of this Agreement: 

1.1. The term “Affiliate” shall mean with respect to any individual, corporation, partnership, association, trust, or any
other entity (in each case, a “Person”), any Person which, directly or indirectly, controls, is controlled by or is under common control with such Person, including, without limitation any general partner, officer or director of
such Person and any venture capital fund now or hereafter existing which is controlled by or under common control with one or more general partners or shares the same management company with such Person. 

1.2. The term “Board” shall mean the Board of Directors of the Company. 

1.3. The term “Common Stock” shall mean shares of the Company’s common stock. 

1.4. The term “Exchange Act” shall mean the Securities Exchange Act of 1934, as amended, and the rules and regulations
promulgated thereunder. 
 1.5. The term “Form S-3” means such form under the
Securities Act as in effect on the date hereof or any registration form under the Securities Act subsequently adopted by the SEC which permits inclusion or incorporation of substantial information by reference to other documents filed by the Company
with the SEC. 
 1.6. The term “GAAP” shall mean generally accepted accounting principles. 

1.7. The term “Holder” shall mean any Person owning or having the right to acquire Registrable Securities or any assignee
thereof in accordance with Section 2.12 hereof. 
 1.8. The Term “Immediate Family Member” shall mean a child,
stepchild, grandchild, parent, stepparent, grandparent, spouse, sibling, mother-in-law, father-in-law, son-in-law, daughter-in-law, brother-in-law, or sister-in-law, including adoptive relationships, of a person referred to herein. 

1.9. The term “Initiating Holders” means, collectively, any Holders who properly initiate a registration request under this
Agreement. 

  
 2 

 1.10. The term “IPO” means the Company’s first underwritten public offering
of its Common Stock to the general public that is effected pursuant to a registration statement filed with, and declared effective by, the SEC under the Securities Act. 

1.11. The term “Major Investor” means, any Investor that, collectively with such Investor’s Affiliates, holds at least
five million (5,000,000) shares of Registrable Securities (subject to appropriate adjustment for stock splits, stock dividends, combinations and other similar recapitalizations affecting such shares). 

1.12. The term “New Securities” shall mean equity securities of the Company, whether now authorized or not, or rights,
options, or warrants to purchase said equity securities, or securities of any type whatsoever that are, or may become, convertible into or exchangeable into or exercisable for said equity securities; provided, however, that the term “New
Securities” does not include any of the following (collectively, the “Excluded Securities”): (i) shares of Common Stock issued or deemed issued as a dividend or distribution on the Preferred Stock; (ii) shares of
Common Stock issued or issuable by reason of a dividend, stock split, split-up or other distribution on shares of Common Stock; (iii) shares of Common Stock or Preferred Stock issued or deemed issued to officers, employees or directors of, or
consultants to, the Company or any of its subsidiaries pursuant to a plan, agreement or arrangement approved by the Board; (iv) shares of Common Stock or convertible securities actually issued upon the exercise of options or shares of Common
Stock actually issued upon the conversion or exchange of convertible securities, in each case provided such issuance is pursuant to the terms of such option or convertible security; (v) shares of Common Stock or Preferred Stock issued or
issuable in connection with strategic alliances or commercial relationships approved by the Board; (vi) shares of Common Stock or Preferred Stock issued or issuable to banks, equipment lessors or other financial institutions, or to real
property lessors, pursuant to a debt financing, equipment leasing or real property leasing transaction approved by the Board; (vii) shares of Common Stock issued or issuable pursuant to a Qualifying Public Offering (as defined below);
(viii) shares of Common Stock or Preferred Stock issued or issuable pursuant to the acquisition of another corporation by the Company by merger, purchase of all or substantially all of the assets or other reorganization or pursuant to a joint
venture agreement, provided, that such issuances are approved by the Board; (ix) shares of Series E Preferred Stock issued and sold pursuant to the Series E Purchase Agreement and the Common Stock issuable upon conversion thereof;
(x) shares of Series A Preferred Stock and Series B Preferred Stock, and the Common Stock issuable upon conversion of such Series A Preferred Stock and Series B Preferred Stock, issuable upon the exercise of those certain warrants issued to
ATEL Ventures, Inc. to purchase up to an aggregate of 178,571 shares of Series A Preferred Stock and 243,506 shares of Series B Preferred Stock (subject to appropriate adjustment for stock splits, stock dividends, combinations and other similar
recapitalizations affecting such shares) (collectively, the “ATEL Warrants”); (xi) shares of Series C Preferred Stock and the Common Stock issuable upon conversion of such Series C Preferred Stock, issuable upon the exercise of
that certain warrant issued to Altis Semiconductor to purchase up to an aggregate of 2,857,143 shares of Series C Preferred Stock (subject to appropriate adjustment for stock splits, stock dividends, combinations and other similar recapitalizations
affecting such shares) (the “Altis Warrant”); and (xii) shares of Common Stock or rights or warrants to purchase shares of Common Stock and the Common Stock issuable upon exercise of such rights or warrants issued or issuable
to Axon Technologies Corporation pursuant to the terms of that certain Technology License Agreement by and between the Company and Axon Technologies Corporation dated as of January 15, 2007 as such may be amended from time to time. 

  
 3 

 1.13. The term “Qualifying Public Offering” shall mean a firm-commitment
underwritten public offering pursuant to an effective registration statement under the Securities Act in which gross proceeds received by the Corporation shall be at least thirty million dollars ($30,000,000). 

1.14. The terms “register,” “registered,” and “registration” refer to a registration
effected by preparing and filing a registration statement or similar document in compliance with the Securities Act, and the declaration or ordering of effectiveness of such registration statement or document. 

1.15. The term “Registrable Securities” means (i) the Common Stock issuable or issued upon conversion of the Preferred
Stock; (ii) any Common Stock issued or issuable upon conversion of any capital stock of the Company now held by the Investors or acquired by the Investors after the date hereof; (iii) any Common Stock issued, or Common Stock issuable or
issued upon conversion of Preferred Stock issued, in a transaction that is excluded from the definition of New Securities if the Board, including a majority of the Preferred Director(s) then serving on the Board, determines that such shares should
receive registration rights under Section 2.2 hereof; (iv) the Common Stock issued or issuable upon exercise of the warrants issued to Axon Technologies Corporation pursuant to the terms of that certain Technology License Agreement
by and between the Company and Axon Technologies Corporation dated as of January 15, 2007, as such may be amended from time to time; (v) the Common Stock issued or issuable (the “ATEL Common Shares”) upon conversion of up
to 178,571 shares of Series A Preferred Stock and up to 243,506 shares of Series B Preferred Stock (subject to appropriate adjustment for stock splits, stock dividends, combinations and other similar recapitalizations affecting such shares) issuable
upon exercise of the ATEL Warrants; (vi) the Common Stock issued or issuable (the “Altis Common Shares”) upon conversion of up to 2,857,143 shares of Series C Preferred Stock (subject to appropriate adjustment for stock splits,
stock dividends, combinations and other similar recapitalizations affecting such shares) issuable upon exercise of the Altis Warrant; (vii) the Common Stock issued or issuable (the “Opus Common Shares”) upon conversion of
shares of Preferred Stock (subject to appropriate adjustment for stock splits, stock dividends, combinations and other similar recapitalizations affecting such shares) issuable upon exercise of warrants issued by the Company to Opus Bank; and
(viii) any Common Stock of the Company issued (or issuable upon the conversion or exercise of any warrant, right or other security which is issued) as a dividend or other distribution with respect to, or upon conversion of, in exchange for, or
in replacement of, the shares referenced in clauses (i) through (vii), inclusive, above, excluding in all cases, however, any Registrable Securities sold by a person in a transaction in which his rights under Section 2 hereof are
not duly assigned or any shares for which registration rights have terminated pursuant to Section 2.15 of this Agreement. 

1.16. The term “Registrable Securities then outstanding” means the number of shares determined by adding the number of shares
of Common Stock which are then outstanding, and the number of shares of Common Stock issuable pursuant to then exercisable or convertible securities which are Registrable Securities or are securities that are convertible into or exercisable for
securities that are Registrable Securities. 
 1.17. The term “Restated Articles” has the meaning set forth in the Series E
Purchase Agreement. 

  
 4 

 1.18. The term “SEC” means the Securities and Exchange Commission. 

1.19. The term “SEC Rule 144” means Rule 144 promulgated by the SEC under the Securities Act (or any similar or successor
rule). 
 1.20. The term “SEC Rule 144(k)” means Rule 144(k) promulgated by the SEC under the Securities Act (or any
similar or successor rule). 
 1.21. The term “SEC Rule 145” means Rule 145 promulgated by the SEC under the Securities Act
(or any similar or successor rule). 
 1.22. The term “Securities Act” means the Securities Act of 1933, as amended, and
the rules and regulations promulgated thereunder. 
 1.23. The term “Preferred Directors” means director(s) of the Company
elected by the holders of the Preferred Stock, exclusively and as a separate class, pursuant to the Fifth Amended and Restated Voting Agreement of even date herewith, by and among the Company, the Investors and the shareholders of the Company listed
on Schedule A attached thereto (the “Voting Agreement”). 
 1.24. The term “Violation” means, with respect
to a registration statement filed pursuant to Sections 2.1, 2.2 or 2.11 hereof, losses, claims, damages, or liabilities (joint or several) to which a party hereto may become subject under the Securities Act, the Exchange Act or
other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereof) arise out of or are based upon any of the following statements, omissions or violations: (i) any untrue statement or alleged
untrue statement of a material fact contained in such registration statement, including any preliminary prospectus or final prospectus contained therein or any amendments or supplements thereto, (ii) the omission or alleged omission to state
therein a material fact required to be stated therein, or necessary to make the statements therein not misleading, or (iii) any violation or alleged violation by any other party hereto, of the Securities Act, the Exchange Act, any state
securities law or any rule or regulation promulgated under the Securities Act, the Exchange Act or any state securities law. 
 2.
Registration Rights. The Company covenants and agrees as follows: 
 2.1. Request for Registration. 

(a) If the Company shall receive at any time after the earlier of (i) five (5) years after the date of this Agreement or
(ii) one hundred eighty (180) days after the effective date of the first registration statement for a public offering of securities of the Company (other than a registration statement relating either to the sale of securities to employees
of the Company pursuant to a stock option, stock purchase or similar plan or a SEC Rule 145 transaction), a written request from the Holders of at least forty percent (40%) of the Registrable Securities then outstanding that the Company file a
registration statement under the Securities Act covering the registration of Registrable Securities representing either an anticipated aggregate public offering price (before any underwriting discounts and commissions) of not less than five million
dollars ($5,000,000) or at least twenty percent (20%) of all Registrable Securities then outstanding, then the Company shall: 
 (i)
within twenty (20) days of the receipt thereof, give written notice of such request to all Holders; 

  
 5 

 (ii) as soon as reasonably practicable, and in any event within sixty (60) days of the
receipt of such request, file a registration statement under the Securities Act covering all Registrable Securities which the Holders request to be registered, subject to the limitations of subsection 2.1(b), within twenty (20) days
of the mailing of such notice by the Company in accordance with Section 6.5; and 
 (iii) use its reasonable best efforts to
cause such registration statement to be declared effective by the SEC as soon as reasonably practicable but in no event later than ninety (90) days after such request. 

(b) If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they
shall so advise the Company as a part of their request made pursuant to subsection 2.1(a) and the Company shall include such information in the written notice referred to in subsection 2.1(a). The underwriter will be selected
by the Company, which underwriter shall be reasonably acceptable to a majority in interest of the Holders whose Registrable Securities are to be included in the underwriting. In such event, the right of any Holder to include such Holder’s
Registrable Securities in such registration shall be conditioned upon such Holder’s participation in such underwriting and the inclusion of such Holder’s Registrable Securities in the underwriting to the extent provided herein. All Holders
proposing to distribute their securities through such underwriting shall (together with the Company as provided in subsection 2.3(e)) enter into an underwriting agreement in customary form with the underwriter or underwriters selected
for such underwriting. Notwithstanding any other provision of this Section 2.1, if the underwriter advises the Company in writing that marketing factors require a limitation of the number of shares to be underwritten, then the Company
shall so advise all Holders of Registrable Securities which would otherwise be underwritten pursuant hereto, and the number of shares of Registrable Securities that may be included in the underwriting shall be allocated among all Holders of
Registrable Securities, including the Initiating Holders, in proportion (as nearly as practicable) to the number of Registrable Securities of the Company owned by each Holder; provided, however, that the number of shares of Registrable
Securities held by the Holders to be included in such underwriting shall not be reduced unless all other securities are first entirely excluded from the underwriting. Any Registrable Securities excluded from or withdrawn from such underwriting shall
be withdrawn from registration. To facilitate the allocation of shares in accordance with the above provisions, the Company or the underwriters may round the number of shares allocated to any Holder to the nearest one hundred (100) shares. 

(c) The Company shall not be obligated to effect, or to take any action to effect, any registration 

(i) pursuant to this Section 2.1: 

(A) If the Company receives the request for registration six (6) months or less before the expected date of filing of the registration
statement for the Company’s IPO; 

  
 6 

 (B) In any particular jurisdiction in which the Company would be required to execute a general
consent to service of process in effecting such registration, unless the Company is already subject to service in such jurisdiction and except as may be required under the Securities Act; 

(C) After the Company has effected two (2) registrations pursuant to this Section 2.1 and such registrations have been
declared or ordered effective; 
 (D) If the Initiating Holders propose to dispose of shares of Registrable Securities that may be
immediately registered on Form S-3 pursuant to a request made pursuant to Section 2.11 below; or 
 (E) If the Registrable
Securities to be included in the registration statement could be sold without restriction under SEC Rule 144(k) within a ninety (90) day period and the Company is currently subject to the periodic reporting requirements of Sections 12(g) or
15(d) of the Exchange Act; or 
 (ii) pursuant to any other provision of this Agreement: 

(A) In any particular jurisdiction in which the Company would be required to execute a general consent to service of process in effecting
such registration, unless the Company is already subject to service in such jurisdiction and except as may be required under the Securities Act; or 

(B) If the Registrable Securities to be included in the registration statement could be sold without restriction under SEC Rule 144(k) within
a ninety (90) day period and the Company is currently subject to the periodic reporting requirements of Sections 12(g) or 15(d) of the Exchange Act. 

(d) Notwithstanding the foregoing, if the Company shall furnish to Holders requesting a registration statement pursuant to this
Section 2.1 a certificate signed by the Chief Executive Officer of the Company stating that in the good faith judgment of the Board it would be materially detrimental to the Company and its shareholders for such registration statement to
be filed and become effective or to remain effective as long as such registration statement would otherwise be required to remain effective because such action would be materially detrimental to the Company and its shareholders, the Company shall
have the right to defer taking action with respect to such filing for a period of not more than ninety (90) days after receipt of the request of the Initiating Holders; provided, however, that the Company may not utilize this
right more than once in any twelve-month period. 
 A registration statement shall not be counted until such time as such registration
statement has been declared effective by the SEC (unless the Initiating Holders withdraw their request for such registration (other than as a result of information concerning the business or financial condition of the Company which is made known to
the Investors after the date on which such registration was requested) and elect not to pay the registration expenses therefor pursuant to Section 2.5). A registration statement shall not be counted if, as a result of an exercise of the
underwriter’s cut-back provisions, less than all of the total number of Registrable Securities that Holders have requested to be included in such registration statement are actually included. 

  
 7 

 2.2. Company Registration. If the Company proposes to register (including for this purpose
a registration effected by the Company for shareholders other than the Holders) any of its stock or other securities under the Securities Act in connection with the public offering of such securities solely for cash (other than registration
statements relating to registrations made pursuant to Sections 2.1 or 2.11 hereof, a registration statement relating either to the sale of securities to employees of the Company pursuant to a stock option, stock purchase or
similar plan or an SEC Rule 145 transaction, a registration on any form which does not include substantially the same information as would be required to be included in a registration statement covering the sale of the Registrable Securities or a
registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities which are also being registered), the Company shall, at such time, promptly give each Holder written notice of such
registration. Upon the written request of each Holder given within twenty (20) days after mailing of such notice by the Company in accordance with Section 6.5, the Company shall, subject to the provisions of Section 2.7,
use its reasonably best efforts to cause to be registered under the Securities Act all of the Registrable Securities that each such Holder has requested to be registered. The Company shall have the right to terminate or withdraw any registration
initiated by it under this Section 2.2 prior to the effectiveness of such registration whether or not any Holder has elected to include securities in such registration. The expenses of such withdrawn registration shall be borne by the
Company in accordance with Section 2.6 hereof. 
 2.3. Obligations of the Company. Whenever required under this
Section 2 to effect the registration of any Registrable Securities, the Company shall, as expeditiously as reasonably possible: 

(a) prepare and file with the SEC a registration statement with respect to such Registrable Securities and use its reasonable best efforts to
cause such registration statement to become effective, and, upon the request of the Holders of a majority of the Registrable Securities registered thereunder, keep such registration statement effective for a period of up to one hundred twenty
(120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; provided, however, such one hundred twenty-day period shall be extended for a period of time equal to the period the
Holder refrains from selling any securities included in such registration at the request of an underwriter of Common Stock (or other securities) of the Company or, such shorter period of time, if the distribution contemplated in the registration
statement has been completed; 
 (b) prepare and file with the SEC such amendments and supplements to such registration statement and the
prospectus used in connection with such registration statement as may be necessary to comply with the provisions of the Securities Act with respect to the disposition of all securities covered by such registration statement for a period of up to one
hundred twenty (120) days or, if earlier, until the distribution contemplated in the registration statement has been completed; 
 (c)
promptly notify the Holders of the effectiveness of such registration statement and furnish to the Holders such numbers of copies of a prospectus, including a preliminary prospectus, in conformity with the requirements of the Securities Act, and
such other documents as they may reasonably request in order to facilitate the disposition of Registrable Securities owned by them; 

  
 8 

 (d) following the effective date of such registration statement, notify the Holders of any
request by the SEC that the Company amend or supplement such registration statement, or the associated prospectus; 
 (e) use its
reasonable best efforts to register and qualify the securities covered by such registration statement under such other securities or Blue Sky laws of such jurisdictions as shall be reasonably requested by the Holders; provided that the
Company shall not be required in connection therewith or as a condition thereto to qualify to do business or to file a general consent to service of process in any such states or jurisdictions, unless the Company is already subject to service in
such jurisdiction and except as may be required by the Securities Act; 
 (f) in the event of any underwritten public offering, enter into
and perform its obligations under an underwriting agreement, in usual and customary form, with the managing underwriter of such offering. Each Holder participating in such underwriting shall also enter into and perform its obligations under such an
agreement; 
 (g) notify each Holder of Registrable Securities covered by such registration statement at any time when a prospectus
relating thereto is required to be delivered under the Securities Act of the happening of any event as a result of which the prospectus included in such registration statement, as then in effect, includes an untrue statement of a material fact or
omits to state a material fact required to be stated therein or necessary to make the statements therein not misleading in light of the circumstances then existing, such obligation to continue for a period of up to one hundred twenty (120) days
or, if earlier, until the distribution contemplated in the registration statement has been completed; 
 (h) cause all such Registrable
Securities registered pursuant to this Agreement hereunder to be listed on a national securities exchange or trading system and each securities exchange and trading system on which similar securities issued by the Company are then listed; 

(i) make generally available to its security holders, and to deliver to each Holder participating in the registration statement, an earnings
statement of the Company that will satisfy the provisions of Section 11(a) of the Securities Act covering a period of 12 months beginning after the effective date of such registration statement as soon as reasonably practicable after the
termination of such 12-month period; 
 (j) provide a transfer agent and registrar for all Registrable Securities registered pursuant
hereunder and a CUSIP number for all such Registrable Securities, in each case not later than the effective date of such registration; and 

(k) use its reasonable best efforts to furnish, at the request of any Holder requesting registration of Registrable Securities pursuant to
this Section 2, on the date on which such Registrable Securities are sold to the underwriter, (i) an opinion, dated such date, of the counsel representing the Company for the purposes of such registration, in form and substance as
is customarily given to underwriters in an underwritten public offering, addressed to 

  
 9 

 
the underwriters, if any, and (ii) a “comfort” letter dated such date, from the independent certified public accountants of the Company, in form and substance as is customarily
given by independent certified public accountants to underwriters in an underwritten public offering, addressed to the underwriters, if any. 

2.4. Furnish Information. It shall be a condition precedent to the obligations of the Company to take any action pursuant to this
Section 2 with respect to the Registrable Securities of any selling Holder that such Holder shall furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended method of disposition of
such securities as shall be reasonably required to effect the registration of such Holder’s Registrable Securities. 
 2.5. Expenses
of Demand Registration. All expenses other than underwriting discounts and commissions incurred in connection with registrations, filings or qualifications pursuant to Section 2.1, including (without limitation) all registration,
filing and qualification fees, printers’ and accounting fees, fees and disbursements of counsel for the Company and the reasonable fees and disbursements, not to exceed Forty Thousand Dollars ($40,000), of one (1) counsel for the selling
Holders shall be borne by the Company; provided, however, that the Company shall not be required to pay for any expenses of any registration proceeding begun pursuant to Section 2.1 if the registration request is
subsequently withdrawn at the request of the Holders of a majority of the Registrable Securities to be registered (in which case all participating Holders shall bear such expenses pro rata based upon the number of Registrable Securities that were to
be included in the withdrawn registration), unless the Holders of a majority of the Registrable Securities agree to forfeit their right to one (1) demand registration pursuant to Section 2.1; provided further, however,
that if at the time of such withdrawal, the Holders have learned of a material adverse change in the condition, business, or prospects of the Company from that known to the Holders at the time of their request and have withdrawn the request with
reasonable promptness after learning of such information, then the Holders shall not be required to pay any of such expenses and shall retain their rights pursuant to Section 2.1. 

2.6. Expenses of Company Registration. The Company shall bear and pay all expenses incurred in connection with any registration, filing
or qualification of Registrable Securities with respect to the registrations pursuant to Section 2.2 hereof for each Holder (which right may be assigned as provided in Section 2.12 hereof), including (without limitation) all
registration, filing, and qualification fees, printers and accounting fees relating or apportionable thereto and the fees and disbursements, not to exceed Forty Thousand Dollars ($40,000) of one (1) counsel for the selling Holders selected by
them, but excluding underwriting discounts and commissions relating to Registrable Securities. 
 2.7. Underwriting Requirements. In
connection with any offering involving an underwriting of shares of the Company’s capital stock pursuant to Section 2.2, the Company shall not be required to include any of the Holders’ securities in such underwriting unless
they accept the terms of the underwriting as agreed upon between the Company and its underwriters, and then only in such quantity as the underwriters determine in their sole discretion will not jeopardize the success of the offering by the Company.
If the total number of securities, including Registrable Securities, requested by shareholders to be included in such offering exceeds the amount of securities to be sold other than by the Company that the underwriters determine in their reasonable
discretion is compatible with the success of the offering, then the 

  
 10 

 
Company shall be required to include in the offering only that number of such securities, including Registrable Securities, which the underwriters and the Company determine in their sole
discretion will not jeopardize the success of the offering. In no event shall any Registrable Securities be excluded from such offering unless all other shareholders’ securities have been first excluded. In the event that the underwriters
determine that less than all of the Registrable Securities requested to be registered can be included in such offering, then the Registrable Securities that are included in such offering shall be apportioned pro rata among the selling Holders based
on the number of Registrable Securities held by all selling Holders or in such other proportions as shall mutually be agreed to by all such selling Holders. Notwithstanding the foregoing, in no event shall (i) the amount of securities of the
selling Holders included in the offering be reduced below thirty-three percent (33%) of the total amount of securities included in such offering, unless such offering is the Company’s IPO in which case the selling Holders may be excluded
beyond this amount if the underwriters make the determination described above and no other shareholder’s securities are included in such offering or (ii) notwithstanding (i) above, any Registrable Securities described in
Section 1.15(i)-(ii) be excluded from such underwriting unless all Registrable Securities described in Section 1.15(iii) are first excluded from such offering. For purposes of the preceding parenthetical concerning
apportionment, for any selling shareholder which is a Holder of Registrable Securities and which is an investment fund, partnership, limited liability company or corporation, the partners, members, retired partners, retired members, shareholders and
Affiliates of such Holder, or the estates and family members of any such partners, retired partners, members and retired members and any trusts for the benefit of any of the foregoing persons shall be deemed to be a single “selling
Holder”, and any pro-rata reduction with respect to such “selling Holder” shall be based upon the aggregate amount of shares carrying registration rights owned by all entities and individuals included in such “selling
Holder,” as defined in this sentence. 
 2.8. Delay of Registration. No Holder shall have any right to obtain or seek an
injunction restraining or otherwise delaying any registration pursuant to this Agreement as the result of any controversy that might arise with respect to the interpretation or implementation of this Section 2. 

2.9. Indemnification. In the event any Registrable Securities are included in a registration statement under this
Section 2: 
 (a) To the extent permitted by law, the Company will indemnify and hold harmless each Holder, the partners,
members, officers, directors and stockholders of each Holder, legal counsel and accountants for each Holder, any underwriter (as defined in the Securities Act) for such Holder and each person, if any, who controls such Holder or underwriter within
the meaning of the Securities Act or the Exchange Act, against any Violation and the Company will pay to each such Holder, underwriter, controlling person or other aforementioned person, any legal or other expenses reasonably incurred by them in
connection with investigating or defending any such loss, claim, damage, liability, or action as such expenses are incurred; provided, however, that the indemnity agreement contained in this subsection 2.9(a) shall not
apply to amounts paid in settlement of any such loss, claim, damage, liability, or action if such settlement is effected without the consent of the Company (which consent shall not be unreasonably withheld), nor shall the Company be liable in any
such case for any such loss, claim, damage, liability, or action to the extent that it arises out of or is based upon a Violation which occurs in reliance upon and in conformity with written information furnished expressly for use in connection with
such registration by any such Holder, underwriter, controlling person or other aforementioned person. 

  
 11 

 (b) To the extent permitted by law, each selling Holder will severally and not jointly indemnify
and hold harmless the Company, each of its directors, each of its officers who has signed the registration statement, each person, if any, who controls the Company within the meaning of the Securities Act, legal counsel and accountants for the
Company, any underwriter, any other Holder selling securities in such registration statement and any controlling person of any such underwriter or other Holder, against any losses, claims, damages, or liabilities (joint or several) to which any of
the foregoing persons may become subject, under the Securities Act, the Exchange Act or other federal or state law, insofar as such losses, claims, damages, or liabilities (or actions in respect thereto) arise out of or are based upon any Violation,
in each case to the extent (and only to the extent) that such Violation occurs in reliance upon and in conformity with written information furnished by such Holder expressly for use in connection with such registration; and each such Holder will
pay, any legal or other expenses reasonably incurred by any person intended to be indemnified pursuant to this subsection 2.9(b), in connection with investigating or defending any such loss, claim, damage, liability, or action;
provided, however, that the indemnity agreement contained in this subsection 2.9(b) shall not apply to amounts paid in settlement of any such loss, claim, damage, liability or action if such settlement is effected without
the consent of the Holder, which consent shall not be unreasonably withheld; provided, further, that, in no event shall any indemnity under this subsection 2.9(b) exceed the net proceeds from the offering received by such
Holder, except in the case of fraud or willful misconduct by such Holder. 
 (c) Promptly after receipt by an indemnified party under this
Section 2.9 of notice of the commencement of any action (including any governmental action), such indemnified party will, if a claim in respect thereof is to be made against any indemnifying party under this Section 2.9,
deliver to the indemnifying party a written notice of the commencement thereof and the indemnifying party shall have the right to participate in, and, to the extent the indemnifying party so desires, jointly with any other indemnifying party
similarly noticed, to assume the defense thereof with counsel mutually satisfactory to the parties; provided, however, that an indemnified party (together with all other indemnified parties which may be represented without conflict by
one counsel) shall have the right to retain one separate counsel, with the reasonable fees and expenses to be paid by the indemnifying party, if there may be one or more legal defenses available to such indemnified party or parties that are
different from or additional to those available to the indemnifying party. The failure to deliver written notice to the indemnifying party within a reasonable time of the commencement of any such action, if prejudicial to its ability to defend such
action, shall relieve such indemnifying party of any liability to the indemnified party under this Section 2.9, but the omission so to deliver written notice to the indemnifying party will not relieve it of any liability that it may have
to any indemnified party otherwise than under this Section 2.9. 
 (d) In order to provide for just and equitable contribution
to joint liability under the Securities Act in any case in which either (i) any Holder exercising rights under this Agreement, or any controlling person of any such Holder, makes a claim for indemnification pursuant to this
Section 2.9 but it is judicially determined (by the entry of a final judgment or decree by a court of competent jurisdiction and the expiration of time to appeal or the denial of the last right of appeal) that such indemnification may
not be enforced in such case 

  
 12 

 
notwithstanding the fact that this Section 2.9 provides for indemnification in such case, or (ii) contribution under the Securities Act may be required on the part of any such
selling Holder or any such controlling person in circumstances for which indemnification is provided under this Section 2.9, then, and in each such case, the Company and such Holder will contribute to the aggregate losses, claims,
damages or liabilities to which they may be subject (after contribution from others) in such proportion as is appropriate to reflect the relative fault of the indemnifying party on the one hand and of the indemnified party on the other in connection
with the statements or omissions that resulted in such loss, liability, claim, damage, or expense as well as any other relevant equitable considerations. The relative fault of the indemnifying party and of the indemnified party shall be determined
by reference to, among other things, whether the untrue or alleged untrue statement of a material fact or the omission or alleged omission to state a material fact relates to information supplied by the indemnifying party or by the indemnified party
and the parties’ relative intent, knowledge, access to information, and opportunity to correct or prevent such statement or omission; provided however, that, in any such case, (I) no such Holder will be required to contribute
any amount in excess of the public offering price of all such Registrable Securities offered and sold by such Holder pursuant to such registration statement, and (II) no person or entity guilty of fraudulent misrepresentation (within the meaning of
Section 11(f) of the Securities Act) will be entitled to contribution from any person or entity who was not guilty of such fraudulent misrepresentation; provided further, that in no event shall a Holder’s liability pursuant
to this subsection 2.9(d), when combined with the amounts paid or payable by such holder pursuant to subsection 2.9(b), exceed the proceeds from the offering (net of any underwriting discounts or commissions) received by such Holder,
except in the case of willful fraud by such Holder. 
 (e) Notwithstanding the foregoing, to the extent that the provisions on
indemnification and contribution contained in the underwriting agreement entered into in connection with the underwritten public offering are in conflict with the foregoing provisions, the provisions in the underwriting agreement shall control. 

(f) Unless otherwise superseded by an underwriting agreement entered into in connection with the underwritten public offering, the
obligations of the Company and Holders under this Section 2.9 shall survive the completion of any offering of Registrable Securities in a registration statement under this Section 2, and shall survive the termination of this
Agreement. 
 2.10. Reports Under Exchange Act. With a view to making available to the Holders the benefits of SEC Rule 144
promulgated under the Securities Act and any other rule or regulation of the SEC that may at any time permit a Holder to sell securities of the Company to the public without registration or pursuant to a registration on Form S-3, the Company agrees to: 
 (a) make and keep public information available, as those terms are
understood and defined in SEC Rule 144, at all times after the effective date of the first registration statement filed by the Company for the offering of its securities to the general public so long as the Company is subject to the periodic
reporting requirements under Sections 13 or 15(d) of the Exchange Act; 
 (b) voluntarily register its Common Stock under Section 12
of the Exchange Act, as is necessary to enable the Holders to utilize Form S-3 for the sale of their 

  
 13 

 
Registrable Securities, such action to be taken as soon as practicable after the end of the fiscal year in which the first registration statement filed by the Company for the offering of its
securities to the general public is declared effective; 
 (c) file with the SEC in a timely manner all reports and other documents
required of the Company under the Securities Act and the Exchange Act; and 
 (d) furnish to any Holder, so long as the Holder owns any
Registrable Securities, forthwith upon request (i) a written statement by the Company that it has complied with the reporting requirements of SEC Rule 144, the Securities Act and the Exchange Act (at any time after it has become subject to such
reporting requirements), or that it qualifies as a registrant whose securities may be resold pursuant to Form S-3 (at any time after it so qualifies), (ii) a copy of the most recent annual or quarterly
report of the Company and such other reports and documents so filed by the Company, and (iii) such other information as may be reasonably requested in availing any Holder of any rule or regulation of the SEC which permits the selling of any
such securities without registration or pursuant to such form. 
 2.11. Form S-3
Registration. In case the Company shall receive from Holders of at least forty percent (40%) of all Registrable Securities then outstanding a written request or requests that the Company effect a registration on Form S-3 and any related qualification or compliance with respect to all or a part of the Registrable Securities owned by such Holder or Holders, the Company will: 

(a) promptly give written notice of the proposed registration, and any related qualification or compliance, to all other Holders; and 

(b) as soon as reasonably practicable, effect such registration and all such qualifications and compliances as may be so requested and as
would permit or facilitate the sale and distribution of all or such portion of such Holder’s or Holders’ Registrable Securities as are specified in such request, together with all or such portion of the Registrable Securities of any other
Holder or Holders joining in such request as are specified in a written request given within fifteen (15) days after receipt of such written notice from the Company; provided, however, that the Company shall not be obligated to
effect any such registration, qualification or compliance, pursuant to this Section 2.11: (1) if Form S-3 is not then available for such offering by the Holders; (2) if the Holders,
together with the holders of any other securities of the Company entitled to inclusion in such registration, propose to sell Registrable Securities and such other securities (if any) at an aggregate price to the public (net of any underwriters’
discounts or commissions) of less than one million dollars ($1,000,000); (3) if the Company shall furnish to the Holders a certificate signed by the President of the Company stating that in the good faith judgment of the Board, it would be
materially detrimental to the Company and its shareholders for such Form S-3 Registration to be filed in the near future, in which event the Company shall have the right to defer the filing of the Form S-3 registration statement for a period of not more than ninety (90) days after receipt of the request of the Holder or Holders under this Section 2.11; provided, however, that the
Company shall not utilize this right more than once in any twelve-month period; and provided further that the Company shall not register any securities for the account of itself or any other shareholder during such ninety-day period
(other than a registration relating solely to the sale of securities of participants in a Company stock plan, a registration relating to a corporate reorganization or transaction under Rule 145 of

  
 14 

 
the Securities Act, a registration on any form that does not include substantially the same information as would be required to be included in a registration statement covering the sale of the
Registrable Securities, or a registration in which the only Common Stock being registered is Common Stock issuable upon conversion of debt securities that are also being registered); (4) if the Company has, within the twelve-month period
preceding the date of such request, already effected two (2) registrations on Form S-3 for the Holders pursuant to this Section 2.11; (5) in any particular jurisdiction in which the
Company would be required to qualify to do business or to execute a general consent to service of process in effecting such registration, qualification or compliance; or (6) during the period ending one hundred eighty (180) days after the
effective date of a registration statement subject to Section 2.2 hereof. 
 (c) Subject to the foregoing, the Company shall
file a registration statement covering the Registrable Securities and other securities so requested to be registered under this Section 2.11 as soon as reasonably practicable after receipt of the request or requests of the Holders. All
expenses incurred in connection with registrations requested pursuant to Section 2.11, including (without limitation) all registration, filing, qualification, printer’s and accounting fees and the reasonable fees and disbursements
of counsel for the selling Holder or Holders, not to exceed Forty Thousand Dollars ($40,000) for each of such registration, and counsel for the Company, but excluding any underwriters’ discounts or commissions associated with Registrable
Securities, shall be borne by the Company. Registrations effected pursuant to this Section 2.11 shall not be counted as demands for registration or registrations effected pursuant to Section 2.1. 

(d) If the Initiating Holders intend to distribute the Registrable Securities covered by their request by means of an underwriting, they
shall so advise the Company as part of their request made pursuant to this Section 2.11 and the Company shall include such information in the written notice referred to in subsection 2.11(a). The provisions of subsection
2.1(b) shall be applicable to such request (with the substitution of Section 2.11 for references to Section 2.1). 

2.12. Assignment of Registration Rights. The rights to cause the Company to register Registrable Securities pursuant to this
Section 2 may be assigned (but only with all related obligations) by a Holder to a transferee or assignee of such securities that (i) is a subsidiary, Affiliate, parent, partner, member, limited partner, retired partner, retired
member or stockholder of a Holder, (ii) is a Holder’s family member or trust for the benefit of an individual Holder, or (iii) acquires at least twenty percent (20%) of the number of shares of Registrable Securities that such
Holder purchases pursuant to the Purchase Agreement (as adjusted for stock splits, stock dividends, combinations and other recapitalizations), provided that: (a) the Company is, within a reasonable time after such transfer,
furnished with written notice of the name and address of such transferee or assignee and the securities with respect to which such registration rights are being assigned; (b) such transferee or assignee agrees in writing to be bound by, and
subject to, the terms and conditions of this Agreement, including, without limitation, the provisions of Section 2.14 below; and (c) such assignment shall be effective only if immediately following such transfer the further
disposition of such securities by the transferee or assignee is restricted under the Securities Act. For the purposes of determining the number of shares of Registrable Securities held by a transferee or assignee, the holdings of transferee or
assignee (i) that is a subsidiary, parent, partner, limited partner, retired partner, member, retired member or stockholder of a Holder; (ii) that is an Affiliate of the Holder, which means with

  
 15 

 
respect to a limited liability company or a limited liability partnership, a fund or entity managed by the same manager or managing member or general partner or management company or by an entity
controlling, controlled by, or under common control with such manager or managing member or general partner or management company, (iii) who is a Holder’s Immediate Family Member, or (iv) that is a trust for the benefit of an
individual Holder or such Holder’s Immediate Family Member, shall be aggregated together and with those of the assigning Holder; provided that all assignees and transferees who would not qualify individually for assignment of
registration rights shall have a single attorney-in-fact for the purpose of exercising any rights, receiving notices or taking any action under this Section 2. It shall be a condition precedent to the obligations of the Company to take any
action pursuant to this Section 2.12 with respect to the Registrable Securities of any selling Holder that such Holder furnish to the Company such information regarding itself, the Registrable Securities held by it, and the intended
method of disposition of such securities as shall be required to effect the registration of such Holder’s Registrable Securities. 

2.13. Limitations on Subsequent Registration Rights. From and after the date of this Agreement, the Company shall not, without the
prior written consent of the Holders of a majority of the Registrable Securities then outstanding, enter into any agreement with any holder or prospective holder of any securities of the Company which would allow such holder or prospective holder
(a) to include such securities in any registration unless under the terms of such agreement, such holder or prospective holder may include such securities in any such registration only to the extent that the inclusion of such securities will
not reduce the amount of the Registrable Securities of the Holders that are included or (b) to demand registration of any securities held by such holder or prospective holder. 

2.14. “Market Stand-Off” Agreement. 

(a) Each Holder hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing
on the date of the final prospectus relating to the Company’s IPO and ending on the date specified by the Company and the managing underwriter (the “Lock-Up Period”) (i) lend, offer, pledge, sell, contract to sell, sell
any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into
or exercisable or exchangeable for Common Stock held immediately prior to the effectiveness of the registration statement for such offering, or (ii) enter into any swap or other arrangement that transfers to another, in whole or in part, any of
the economic consequences of ownership of the Common Stock, whether any such transaction described in clause (i) or (ii) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise. The Lock-Up Period shall
not exceed one hundred eighty (180) days, provided, however, that for the purpose of allowing the underwriters in the Company’s IPO to comply with NASD Rule 2711(f)(4), if (a) during the last seventeen (17) days of the Lock-Up
Period the Company releases earnings results or material news or a material event relating to the Company occurs, or (b) prior to the expiration of the Lock-Up Period, the Company announces that it will release earnings results during the
sixteen-day period beginning on the last day of the Lock-Up Period, then in each such case, the Lock-Up Period may be extended past one hundred eighty (180) days until the expiration of the eighteen-day period beginning on the date of release
of the earnings results or the occurrence of the material news or material event, as applicable. The foregoing provisions of this Section 2.14 shall apply only to the Company’s IPO, shall not

  
 16 

 
apply to the sale of any shares to an underwriter pursuant to an underwriting agreement, and shall only be applicable to the Holders if all officers, directors and greater than one percent
(1%) shareholders of the Company enter into similar agreements. The underwriters in connection with the Company’s IPO are intended third-party beneficiaries of this Section 2.14 and shall have the right, power and authority to
enforce the provisions hereof as though they were a party hereto. Each Holder further agrees to execute such agreements as may be reasonably requested by the underwriters in the Company’s IPO that are consistent with this
Section 2.14 or that are necessary to give further effect thereto within any reasonable timeframe so requested. 
 (b) For
purposes of this Section 2.14, the term “Company” shall include any wholly-owned subsidiary of the Company into which the Company merges or consolidates. In order to enforce the foregoing covenant, the Company may impose stop-transfer instructions with respect to the Registrable Securities of each Holder (and the shares or securities of every other person subject to the foregoing restriction) until the end of such period. 

(c) Each Holder agrees that a legend reading substantially as follows shall be placed on all certificates representing all Registrable
Securities of each Holder (and the shares or securities of every other person subject to the restriction contained in this Section 2.14): 

THE SECURITIES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO A LOCK-UP PERIOD OF 180 DAYS OR MORE AFTER THE EFFECTIVE DATE OF THE
ISSUER’S REGISTRATION STATEMENT FILED UNDER THE ACT, AS AMENDED, AS SET FORTH IN AN AGREEMENT BETWEEN THE COMPANY AND THE ORIGINAL HOLDER OF THESE SECURITIES, A COPY OF WHICH MAY BE OBTAINED AT THE ISSUER’S PRINCIPAL OFFICE. AS A RESULT OF
SUCH AGREEMENT, THESE SHARES MAY NOT BE TRADED PRIOR TO 180 DAYS AFTER THE EFFECTIVE DATE OF THE INITIAL PUBLIC OFFERING OF THE COMMON STOCK OF THE ISSUER HEREOF. SUCH LOCK-UP PERIOD IS BINDING ON TRANSFEREES OF THESE SHARES. 

2.15. Termination of Registration Rights. 

(a) No Holder shall be entitled to exercise any right provided for in this Section 2 after seven (7) years following the
consummation of the IPO. 
 (b) The rights set forth in this Section 2 shall terminate as to any Holder, when the Registrable
Securities held by such Holder (together with any Affiliate of such Holder with whom such Holder must aggregate its sales under SEC Rule 144) could be sold without restriction under SEC Rule 144(k). 

3. Information, Observer and Inspection Rights. 

3.1. Delivery of Financial Statements. The Company shall deliver to each Holder of at least 4,000,000 shares of Preferred Stock
(subject to appropriate adjustment for stock splits, stock dividends, combinations and other similar recapitalizations affecting such shares), or the Common Stock issued upon conversion of such Preferred Stock (each an “Information Rights
Holder”): 
 (a) as soon as reasonably practicable, but in any event within ninety (90) days after the end of each fiscal
year of the Company, an unaudited balance sheet as of the last day of such year, an unaudited statement of operations and an unaudited statement of cash flows for such year and, unless waived by the Board, within one hundred twenty (120) days
after the end of each fiscal year, an audited balance sheet as of the last day of such year, an audited statement of operations and an audited statement of cash flows for such year, such year-end financial
reports to be in reasonable detail, prepared in accordance with GAAP, except that the financial report may (i) be subject to normal year-end audit adjustments and (ii) not contain all notes thereto which may be required in accordance with
GAAP; 

  
 17 

 (b) as soon as reasonably practicable, but in any event within
forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, an unaudited income statement, schedule as to the sources and application of funds for
such fiscal quarter, an unaudited balance sheet and a statement of shareholder’s equity as of the end of such fiscal quarter; 
 (c)
as soon as reasonably practicable, but in any event with forty-five (45) days after the end of each of the first three (3) quarters of each fiscal year of the Company, a statement showing the number of shares of each class and series of
capital stock and securities convertible into or exercisable for shares of capital stock outstanding at the end of the period, the number of common shares issuable upon conversion or exercise of any outstanding securities convertible or exercisable
for common shares and the exchange ratio or exercise price applicable thereto and number of shares of issued stock options and stock options not yet issued but reserved for issuance, if any, all in sufficient detail as to permit the Information
Rights Holder to calculate its percentage equity ownership in the Company and certified by the Chief Financial Officer or Chief Executive Officer of the Company as being true, complete and correct; 

(d) as soon as reasonably practicable, but in any event within thirty (30) days of the end of each month, an unaudited income statement,
an unaudited profit or loss statement; and 
 (e) as soon as reasonably practicable, but in any event thirty (30) days prior to the
end of each fiscal year, a budget and business plan for the next fiscal year prepared on a monthly basis, including balance sheets and sources and applications of funds statements for such months and, as soon as prepared, any other budgets or
revised budgets prepared by the Company; and 
 (f) with respect to the financial statements called for in subsections (a), (b) and
(d) of this Section 3.1, an instrument executed by the Chief Financial Officer and President or Chief Executive Officer of the Company and certifying that such financials were prepared in accordance with GAAP consistently
applied with prior practice for earlier periods (with the exception of footnotes that may be required by GAAP) and fairly present the financial condition of the Company and its results of operation for the periods specified therein, subject to year-end audit adjustments; 
 (g) If for any period the Company shall have any subsidiary whose accounts
are consolidated with those of the Company, then in respect of such period the financial statements delivered pursuant to the foregoing sections shall be the consolidated and consolidating financial statements of the Company and all such
consolidated subsidiaries. 

  
 18 

 (h) Notwithstanding anything else in this Section 3.1 to the contrary, the Company
may cease providing the information set forth in this Section 3.1 during the period starting with the date sixty (60) days prior to the Company’s good faith estimate of the date of filing of, and ending on a date one hundred eighty
(180) days after the effective date of the registration effecting the IPO; provided that the Company is actively employing its reasonable best efforts to cause such registration statement to become effective. 

(i) Notwithstanding the foregoing, it is acknowledged and agreed that the information rights set forth in this Section 3.1 are
not available to any Investor whose shares of Preferred Stock were mandatorily converted into Common Stock for failure to participate in an equity financing round of the Company in accordance with the terms of the Company’s Articles of
Incorporation in effect at the time of such equity financing round. 
 3.2. Inspection. The Company shall permit each Information
Rights Holder, at such Information Rights Holder’s expense, to visit and inspect the Company’s properties, to examine its books of account and records and to discuss the Company’s affairs, finances and accounts with its officers, all
at such reasonable times and as may be reasonably requested by the Information Rights Holder; provided, however, that the Company shall not be obligated pursuant to this Section 3.2 to provide access to any information
which it reasonably considers to be a trade secret or similar confidential information or that would adversely affect the attorney-client privilege between the Company and its counsel. 

3.3. Assignment. The information, observer and inspection rights set forth in this Section 3 may not be assigned or
transferred except that (i) such right is assignable by each Information Rights Holder to any Affiliate of such Information Rights Holder, and (ii) such right is assignable by any Information Rights Holder to any other Information Rights
Holder.  
 3.4. Termination of Information and Inspection Covenants. The covenants set forth in Section 3.1 and
Section 3.2 shall terminate as to Investors and be of no further force or effect immediately prior to (i) the consummation of a Qualifying Public Offering or (ii) upon a Deemed Liquidation Event, as such term is defined in the
Company’s then effective Articles of Incorporation, whichever event shall first occur. 
 3.5. Confidentiality. Each Investor
agrees that such Investor will keep confidential and will not disclose, divulge or use for any purpose, other than to monitor its investment in the Company, any confidential information obtained from the Company pursuant to the terms of this
Agreement, unless such confidential information (i) is known or becomes known to the public in general (other than as a result of a breach of this Section 3.4 by such Investor), (ii) is or has been independently developed or
conceived by the Investor without use of the Company’s confidential information or (iii) is or has been made known or disclosed to the Investor by a third party without a breach of any obligation of confidentiality such third party may
have to the Company; provided, however, that an Investor may disclose confidential information (a) to its attorneys, accountants, consultants, and other professionals to the extent necessary to obtain their services in connection
with monitoring its investment in the Company, (b) to any prospective investor of any Registrable Securities from such Investor as long as such 

  
 19 

 
prospective investor agrees to be bound by the provisions of this Section 3.4, (c) to any Affiliate, financing source, partner, member, stockholder or wholly owned subsidiary of
such Investor in the ordinary course of business, or (d) as may otherwise be required by law, provided that the Investor takes reasonable steps to minimize the extent of any such required disclosure. 

4. Right of First Offer. 

4.1. Right of First Offer. Subject to the terms and conditions specified in this Section 4.1, and applicable securities
laws, in the event the Company proposes to offer or sell any New Securities, the Company shall first make an offering of such New Securities to each Major Investor in accordance with the following provisions of this Section 4.1. A Major
Investor shall be entitled to apportion the right of first offer hereby granted it among itself and its partners, members and Affiliates in such proportions as it deems appropriate. 

(a) The Company shall deliver a notice (the “Offer Notice”), in accordance with the provisions of Section 6.5
hereof, to each of the Major Investors stating (i) its bona fide intention to offer such New Securities, (ii) the number of such New Securities to be offered, and (iii) the price and terms, if any, upon which it proposes to offer such
New Securities. 
 (b) By written notification received by the Company, within fifteen (15) calendar days after mailing of the Offer
Notice, each of the Major Investors may elect to purchase or obtain, at the price and on the terms specified in the Offer Notice, up to that portion of such New Securities which equals the proportion that the number of shares of Registrable
Securities then held by such Major Investor bears to the total number of shares of Common Stock of the Company then outstanding (assuming full conversion and exercise of all convertible or exercisable securities and exercise in full of all
outstanding options and warrants); provided, however, that such Major Investor shall have no right to purchase any such New Securities if such Investor cannot demonstrate to the Company’s reasonable satisfaction that such Investor
is, at the time of the proposed issuance of such New Securities, an “accredited investor” as defined in Regulation D under the Securities Act. The Company shall promptly, in writing, inform each Major Investor that elects to purchase all
the shares available to it (each, a “Fully-Exercising Investor”) of any other Major Investor’s failure to do likewise. During the fifteen (15) calendar-day period commencing after receipt of such information, each Fully-Exercising Investor shall be entitled to obtain that portion of the New Securities for which Major Investors were entitled to subscribe but which were not subscribed for by the Major Investors which is equal
to the proportion that the number of shares of Registrable Securities then held by such Fully-Exercising Investor bears to the total number of shares of Registrable Securities then held by all Fully-Exercising Investors who wish to purchase such unsubscribed shares. 
 (c) If all New Securities
referred to in the Offer Notice are not elected to be purchased or obtained as provided in subsection 4.1(b) hereof, the Company may, during the sixty (60) day period following the expiration of the period provided in subsection
4.1(b) hereof, offer the remaining unsubscribed portion of such New Securities (collectively, the “Refused Securities”) to any person or persons at a price not less than, and upon terms no more favorable to the offeree than,
those specified in the Offer Notice. If the Company does not enter into an agreement for the sale of the New Securities within such period, or if such agreement is not consummated within thirty (30) days of the execution thereof, the right
provided hereunder shall be deemed to be revived and such New Securities shall not be offered unless first reoffered to the Major Investors in accordance with this Section 4.1. 

  
 20 

 (d) The right of first offer in this Section 4.1 shall not be applicable to any
Excluded Securities. 
 (e) The right of first offer set forth in this Section 4.1 may not be assigned or transferred except
that (i) such right is assignable by each Major Investor to any Affiliate of such Major Investor, and (ii) such right is assignable by any Major Investor to any other Major Investor. Notwithstanding the foregoing, it is acknowledged and
agreed that the right of first offer set forth in this Section 4.1 shall not be available to any Investor whose shares of Preferred Stock were mandatorily converted into Common Stock for failure to participate in an equity financing round of
the Company in accordance with the terms of the Company’s Articles of Incorporation in effect at the time of such equity financing round 

(f) In lieu of complying with the provisions of this Section 4.1, the Company may elect to give notice to the Major Investors
within thirty (30) days after the issuance of New Securities. Such notice shall describe the type, price and terms of the New Securities. Each Major Investor shall have twenty (20) days from the date of receipt of such notice to elect to
purchase up to the number of New Securities that would, if purchased by such Major Investor, maintain such Major Investor’s percentage ownership position, calculated as set forth in subsection 4.1(b) prior to giving effect to the
issuance of such New Securities. The closing of such sale shall occur within sixty (60) days of the date of notice to the Major Investors. 

4.2. Termination. The provisions of this Section 4 shall terminate and be of no further force or effect immediately prior
to (i) the consummation of a Qualifying Public Offering or (ii) upon a Deemed Liquidation Event, as such term is defined in the Company’s then effective Articles of Incorporation, whichever event shall first occur. 

5. Additional Covenants. 

5.1. Insurance. The Company shall use its reasonable best efforts to maintain, from financially sound and reputable insurers,
(i) Directors and Officers Errors and Omissions insurance in an amount reasonably satisfactory to the Board and (ii) term “key-person” insurance on Narbeh Derhacobian, in a minimum of $1,000,000 or an amount reasonably
satisfactory to the Board, until such time as the Board determines that such insurance should be discontinued. The “key person” policy shall name the Company as loss payee and neither policy shall be cancelable by the Company without prior
approval of the Board. 
 5.2. Employee Agreements. The Company will cause each person now or hereafter employed by it or any
subsidiary (or engaged by the Company or any subsidiary as a consultant or independent contractor) with access to confidential information and/or trade secrets to enter into a non-disclosure and proprietary rights assignment agreement. In addition,
the Company shall not amend, modify, terminate, waive or otherwise alter, in whole or in part, any above-referenced agreement or any restricted stock agreement between the Company and any employee without the approval of the Board. 

  
 21 

 5.3. Employee Vesting. Unless otherwise approved by the Board, all future employees and
consultants of the Company who shall purchase, or receive options to purchase, shares of the Company’s capital stock following the date hereof shall be required to execute stock purchase or option agreements providing for (i) vesting of
shares over a four-year period with the first twenty five percent (25%) of such shares vesting following twelve (12) months of continued employment or services, and the remaining shares vesting in equal monthly installments over the
following thirty six (36) months and (ii) a 180-day lockup period in connection with the Company’s IPO. The Company shall retain a “right of first refusal” on employee transfers until the Company’s IPO and the right to
repurchase unvested shares at cost. 
 5.4. Qualified Small Business Stock Status. In the event that the Company proposes to take an
action or engage in a transaction that would reasonably be expected to result in the Shares no longer being “qualified small business stock” within the meaning of Section 1202(c) of the Internal Revenue Code of 1986, as amended (the
“Code”), the Company shall notify the Investors and consult in good faith to devise a mutually agreeable and reasonable alternative course of action or transaction structure that would preserve such status. In addition, the Company
shall submit to the Investors and to the Internal Revenue Service any reports that may be required under Section 1202(d)(1)(C) of the Code and any related Treasury Regulations. In addition, within ten (10) days after any Investor has
delivered to the Company a written request therefor, the Company shall deliver to such Investor a written statement informing the Investor whether, in the Company’s good-faith judgment after a reasonable investigation, such Investor’s
interest in the Company constitutes “qualified small business stock” as defined in Section 1202(c) of the Code, or would constitute “qualified small business stock,” if determination of whether stock constitutes
“qualified small business stock” were made by taking into account the modifications set forth in Section 1045(b)(4) of the Code. The Company’s obligation to furnish a written statement pursuant to this Section 5.4
shall continue notwithstanding the fact that a class of the Company’s stock may be traded on an established securities market. 
 5.5.
Press Releases. 
 (a) Any press release issued by the Company in connection with its sale and issuance of Preferred Stock shall
have received prior approval by the Board and the Company shall be responsible for any expenses incurred in connection with such press release. 

(b) In the event a Company press release contains the name of Applied Ventures, LLC or its Affiliate, such press release shall have received
approval from Applied Ventures, LLC prior to its issuance. 
 (c) The Company acknowledges that Serge Dassault (“M.
Dassault”) or his affiliates, representatives or agents may be required to give or issue a notice or press release concerning M. Dassault’s investment in the Company in compliance with the applicable laws of France; provided, that any
such notice or press release shall not contain the name of Applied Ventures, LLC or its Affiliate without the prior approval by Applied Ventures, LLC. 

(d) The Company shall not issue a press release containing the name of Altera Corporation or any of its Affiliates without the prior written
consent of Altera Corporation. 

  
 22 

 (e) The Company shall not issue a press release containing the name of Microchip Technology
Incorporated or any of its Affiliates without the prior written consent of Microchip Technology Incorporated. 
 (f) In the event that
Integrated Silicon Solution Inc. or any of its Affiliates becomes a party to this Agreement as an Investor, the Company shall not issue a press release containing the name of Integrated Silicon Solution Inc. or any of its Affiliates without the
prior written consent of Integrated Silicon Solution Inc. 
 5.6. Military Contracts. The Company shall notify M. Dassault before
entering into an agreement with a military institution. For the sake of clarity, the parties hereto acknowledge and agree that such notice obligation of the Company shall not provide M. Dassault with the right to approve or disapprove any such
agreement with a military institution or the Company’s entering any such agreement. 
 5.7. Management Carve-Out Plan. 

(a) Following the execution of this Agreement, the Company shall adopt a management carve-out plan (the “Carve-Out Plan”), as contemplated by the Restated Articles, for payments to certain service providers of the Company (the “Plan Participants”) upon a Deemed Liquidation Event (as defined in
the Restated Articles). Such Carve-Out Plan shall contain the following material terms (the “Carve-Out Plan Terms”): 

(i) Following payment in full of the Series E First Liquidation Preference (as defined in the Restated Articles) to holders of shares of
Series E Preferred Stock, the aggregate amount to be paid to the Plan Participants under the Carve-Out Plan will be established in an amount equal to five percent (5%) (the “Carve-Out Percentage”) of the remaining proceeds from
the Deemed Liquidation Event following the payment of the Series E First Liquidation Preference. 
 (ii) If the value of the Company in the
Deemed Liquidation Event exceeds $300,000,000, but is equal to or less than $400,000,000, then the Carve-Out Percentage will increase to seven and one-half percent (7.5%) for the amount by which such value exceeds $300,000,000. 

(iii) If the value of the Company in the Deemed Liquidation Event exceeds $4,000,000, then the Carve-Out Percentage will increase to seven
and one-half percent (7.5%) for the amount by which such value exceeds $300,000,000 up to $400,000,000, and then the Carve-Out Percentage will increase to ten percent (10%) for the amount by which such value exceeds $400,000,000. 

(b) Following the adoption and implementation of the Carve-Out Plan pursuant to Section 5.7(a), the Carve-Out Plan Terms set
forth herein and therein may only be modified, rescinded or amended upon approval by the Board and holders of ninety percent (90%) of the outstanding shares of Series E Preferred Stock. 

5.8. Termination of Certain Covenants. The covenants set forth in these Sections 5.1 through 5.7 shall terminate and be
of no further force or effect upon (a) the consummation of a Qualifying Public Offering; (b) upon a Deemed Liquidation Event, as such 

  
 23 

 
term is defined in the Company’s then effective Amended and Restated Articles of Incorporation; and (c) the Company first becoming subject to the periodic reporting requirements of
Sections 12(g) or 15(d) of the Exchange Act, whichever event shall first occur. 
 6. Miscellaneous. 

6.1. Transfers, Successors and Assigns. The terms and conditions of this Agreement shall inure to the benefit of and be binding upon
the respective successors and assigns of the parties. Nothing in this Agreement, express or implied, is intended to confer upon any party other than the parties hereto or their respective successors and assigns any rights, remedies, obligations,
or liabilities under or by reason of this Agreement, except as expressly provided in this Agreement. 
 6.2. Governing Law. This
Agreement shall be governed by and construed in accordance with the General Corporation Law of California, without regard to its principles of conflicts of laws. 

6.3. Counterparts. This Agreement may be executed in two or more counterparts, each of which shall be deemed an original, but all of
which together shall constitute one and the same instrument. This Agreement may also be executed and delivered by facsimile signature and in two or more counterparts, each of which shall be deemed an original, but all of which together shall
constitute one and the same instrument. 
 6.4. Titles and Subtitles. The titles and subtitles used in this Agreement are used for
convenience only and are not to be considered in construing or interpreting this Agreement. 
 6.5. Notices. All notices and other
communications given or made pursuant to this Agreement shall be in writing and shall be deemed effectively given: (a) upon personal delivery to the party to be notified, (b) when sent by confirmed electronic mail or facsimile if sent
during normal business hours of the recipient, and if not so confirmed, then on the next business day, (c) five (5) days after having been sent by registered or certified mail, return receipt requested, postage prepaid, or (d) one
(1) day after deposit with a nationally recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications shall be sent to the respective parties at their address as set forth on the signature
page or Schedule A hereto, or to such email address, facsimile number or address as subsequently modified by written notice given in accordance with this Section 6.5. If notice is given to the Company, a copy shall also be
sent to Mark A. Leahy, Esq. c/o Fenwick & West LLP, Silicon Valley Center, 801 California Street, Mountain View, California, 94041, Facsimile: (650) 938-5200. 

6.6. Costs of Enforcement. If any Party to this Agreement seeks to enforce its rights under this Agreement by legal proceedings, the
non-prevailing Party shall pay all costs and expenses incurred by the prevailing Party, including, without limitation, all reasonable attorneys’ fees. 

6.7. Amendments and Waivers. Except as provided in Section 5.7 above, any term of this Agreement may be amended and the
observance of any term of this Agreement may be waived (either generally or in a particular instance and either retroactively or prospectively), 

  
 24 

 
with and only with the written consent of the Company and the holders of a majority of the Registrable Securities then held by the Investors; provided, however, that none of the
Registrable Securities held by Axon Technologies Corporation, ATEL Ventures, Inc., Altis Semiconductor or Opus Bank shall be included in any manner in the calculation set forth in this sentence; and provided further, however, that the
Investors may not amend the Agreement in any manner that would cause the ATEL Common Shares, the Altis Common Shares or the Opus Common Shares to no longer be Registrable Securities hereunder. Any amendment or waiver effected in accordance with this
paragraph shall be binding upon each holder of any Registrable Securities then outstanding, each future holder of all such Registrable Securities, and the Company. Notwithstanding the foregoing, this Agreement may not be amended or terminated and
the observance of any term hereunder may not be waived with respect to any Investor without the written consent of such Investor, unless such amendment, termination or waiver applies to all Investors in the same fashion (it being agreed that a
waiver of the provisions of Section 4 with respect to a particular transaction shall be deemed to apply to all Investors in the same fashion if such waiver does so by its terms, notwithstanding the fact that certain Investors may
nonetheless, by agreement with the Company, purchase securities in such transaction). The Company shall give prompt written notice of any amendment or termination hereof or waiver hereunder to any party hereto that did not consent in writing to such
amendment, termination or waiver. Any amendment, termination or waiver effected in accordance with this Section 6.7 shall be binding on all parties hereto, even if they do not execute such consent. No waivers of or exceptions to any
term, condition or provision of this Agreement, in any one or more instances, shall be deemed to be, or construed as, a further or continuing waiver of any such term, condition or provision. 

6.8. Severability. Whenever possible, each provision or portion of any provision of this Agreement will be interpreted in such manner
as to be effective and valid under applicable law, but if any provision or portion of any provision of this Agreement is held to be invalid, illegal or unenforceable in any respect under any applicable law or rule in any jurisdiction, such
invalidity, illegality or unenforceability will not affect any other provision or portion of any provision in such jurisdiction, and this Agreement will be reformed, construed and enforced in such jurisdiction as if such invalid, illegal or
unenforceable provision or portion of any provision had never been herein. 
 6.9. Aggregation of Stock. All shares of Registrable
Securities held or acquired by Affiliates shall be aggregated together for the purpose of determining the availability of any rights under this Agreement. 

6.10. Entire Agreement. This Agreement (including the Schedules and Exhibits hereto, if any) constitutes the full and entire
understanding and agreement between the parties with respect to the subject matter hereof, and any other written or oral agreement relating to the subject matter hereof existing between the parties, including, without limitation, the Prior
Agreement, are expressly canceled. 
 6.11. Transfers of Rights. Each Investor hereto hereby agrees that it will not, and may, not
assign any of its rights and obligations hereunder, unless such rights and obligations are assigned by such Investor to (a) any person or entity to which Registrable Securities are transferred by such Investor, or (b) to any Affiliate of
such Investor, and, in each case, such transferee shall be deemed an “Investor” for purposes of this Agreement; provided 

  
 25 

 
that such assignment of rights shall be contingent upon the transferee providing a written instrument to the Company notifying the Company of such transfer and assignment and agreeing in writing
to be bound by the terms of this Agreement. 
 6.12. Dispute Resolution. Any unresolved controversy or claim arising out of or
relating to this Agreement, except as (i) otherwise provided in this Agreement, or (ii) any such controversies or claims arising out of either party’s intellectual property rights for which a provisional remedy or equitable relief is
sought, shall be submitted to arbitration by one arbitrator mutually agreed upon by the parties, and if no agreement can be reached within thirty (30) days after names of potential arbitrators have been proposed by the American Arbitration
Association (the “AAA”), then by one arbitrator having reasonable experience in corporate finance transactions of the type provided for in this Agreement and who is chosen by the AAA. The arbitration shall take place in San Jose,
California, in accordance with the AAA rules then in effect, and judgment upon any award rendered in such arbitration will be binding and may be entered in any court having jurisdiction thereof. There shall be limited discovery prior to the
arbitration hearing as follows: (a) exchange of witness lists and copies of documentary evidence and documents relating to or arising out of the issues to be arbitrated, (b) depositions of all party witnesses and (c) such other
depositions as may be allowed by the arbitrators upon a showing of good cause. Depositions shall be conducted in accordance with the Federal Arbitration Act, 9 U.S.C. §1 et seq, the arbitrator shall be required to provide in writing to the
parties the basis for the award or order of such arbitrator, and a court reporter shall record all hearings, with such record constituting the official transcript of such proceedings. Each party will bear its own costs in respect of any disputes
arising under this Agreement. Each of the parties to this Agreement consents to personal jurisdiction for any equitable action sought in the U.S. District Court for the District of California or any court of the State of California having subject
matter jurisdiction. 
 6.13. Delays or Omissions. No delay or omission to exercise any right, power or remedy accruing to any party
under this Agreement, upon any breach or default of any other party under this Agreement, shall impair any such right, power or remedy of such non-breaching or non-defaulting party nor shall it be construed to be a waiver of any such breach or
default, or an acquiescence therein, or of or in any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. Any
waiver, permit, consent or approval of any kind or character on the part of any party of any breach or default under this Agreement, or any waiver on the part of any party of any provisions or conditions of this Agreement, must be in writing and
shall be effective only to the extent specifically set forth in such writing. All remedies, either under this Agreement or by law or otherwise afforded to any party, shall be cumulative and not alternative. 

6.14. Further Assurances. Subject to the terms and conditions herein provided, each of the parties hereto agrees to use its best
efforts to take, or cause to be taken, all action and to do, or cause to be done, all things necessary, proper, or advisable under applicable laws and regulations to consummate and make effective the transactions contemplated by this Agreement,
including using its best efforts to obtain all necessary waivers, consents, and approvals, and effecting all necessary registrations and filings. 

6.15. Lender Relationship. Notwithstanding anything herein to the contrary, nothing contained in this Agreement shall affect, limit or
impair the rights and remedies of Opus 

  
 26 

 
Bank, any of its Affiliates or any other lender in their capacity as lenders to the Company or any of its Affiliates pursuant to any agreement under which the Company or such Affiliate has
borrowed money. Without limiting the generality of the foregoing, none of Opus Bank or any such other Person, in exercising its rights as a lender, including making its decision on whether to foreclose on any collateral security, will have any duty
to consider (a) its status as a direct or indirect shareholder of the Company, (b) the interests of the Company or any of its Affiliates or (c) any duty it may have to any other direct or indirect shareholder of the Company, except as
may be required under the applicable loan documents. 
 [Remainder of Page Intentionally Left Blank] 

  
 27 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	THE COMPANY:
	
	ADESTO TECHNOLOGIES CORPORATION
		
	By:		 /s/ Narbeh Derhacobian

		
	Name:		Narbeh Derhacobian
		
	Title:		President and Chief Executive Officer
		
	Address:		 1250 Borregas Avenue
 Sunnyvale, CA
94089

  
 [SIGNATURE PAGE TO
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	ARCH Venture Fund VI, L.P.
	By:		ARCH Venture Partners VI, L.P.
	Its:		General Partner
	By:		ARCH Venture Partners VI, LLC
	Its:		General Partner
		
	By:		 /s/ Keith Crandell

	Its:		Managing Director

  
 [SIGNATURE PAGE TO
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	 ATA Ventures II, L.P., by its General Partner
ATA Management II, LLC

	 ATA Affiliates Fund II, L.P., by its General Partner
ATA Management II, LLC

	 ATA Investment Fund II, L.P., by its General Partner
ATA Management II,
LLC

		
	By:		 /s/ T. Peter Thomas

			T. Peter Thomas, Managing Director

  
 [SIGNATURE PAGE TO
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	Harris & Harris Group, Inc.
		
	By:		 /s/ Sandra M. Forman

			Sandra M. Forman
			General Counsel

  
 [SIGNATURE PAGE TO
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	Applied Ventures, LLC
		
	By:		 /s/ J. Christopher Moran

	Name:		J. Christopher Moran
	Title:		Vice President and General Manager

  
 [SIGNATURE PAGE TO
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

					
	INVESTORS:
	
	Adams Street 2006 Direct Fund, L.P.
		
	By:		ASP 2006 Direct Management, LLC, its General Partner
	By:		Adams Street Partners, LLC, its Managing Member
		
	By:		 /s/ Thomas D. Berman

			Name:		 Thomas D. Berman

			Title:		Partner
	
	Adams Street 2007 Direct Fund, L.P.
		
	By:		ASP 2007 Direct Management, LLC, its General Partner
	By:		Adams Street Partners, LLC, its Managing Member
		
	By:		 /s/ Thomas D. Berman

			Name:		 Thomas D. Berman

			Title:		Partner

  
 [SIGNATURE PAGE TO
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	Microchip Technology Incorporated
		
	By:		 /s/ Steve Drehobl

		
	Name:		 Steve Drehobl

		
	Title:		 Vice President

  
 [SIGNATURE PAGE TO
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
		
	By:		 /s/ Serge Dassault

			Serge Dassault

  
 [SIGNATURE PAGE TO
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 IN WITNESS WHEREOF, the parties hereto have executed this Fourth Amended and Restated
Investors’ Rights Agreement as of the date first above written. 
  

			
	INVESTORS:
	
	Altera Corporation
		
	By:		 /s/ William Hata

		
	Name:		 William Y. Hata

		
	Title:		 SVP Worldwide Operations and Engineering

  
 [SIGNATURE PAGE TO
FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT] 

 SCHEDULE A 

INVESTORS 
  

	
	 Investor

	 ARCH Venture Fund VI, L.P.

	
	 ATA Ventures II, L.P.

	
	 ATA Affiliates Fund II, L.P.

	
	 ATA Investment Fund II, L.P.

	
	 Harris & Harris Group, Inc.

	
	 Adams Street 2006 Direct Fund, L.P.

	
	 Adams Street 2007 Direct Fund, L.P.

	
	 Applied Ventures, LLC

	
	 Rambus Inc.

	
	 Microchip Technology Incorporated

	
	 ATEL Ventures, Inc.

	
	
	 Serge Dassault

	
	 Altis Semiconductor

	
	 Altera Corporation

	
	 Opus Bank

 Exhibit 4.01 

AMENDMENT NO. 1 TO 

FOURTH AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT 

This Amendment (this “Amendment”) to that certain Fourth Amended and Restated Investors’ Rights Agreement, dated as of
August 19, 2013 (the “Rights Agreement”), is made as of October 23 2015 by and among Adesto Technologies Corporation, a Delaware corporation (the “Company”) and the Investors listed on Schedule I of the
Rights Agreement (the “Investors”). Capitalized terms used but not defined herein shall have the meanings ascribed to them in the Rights Agreement. 

RECITALS 
 A.
WHEREAS, pursuant to Section 6.7 of the Rights Agreement, the Rights Agreement may be amended with the written consent of the Company and the Investors that in the aggregate hold at least a majority of the currently outstanding Registrable
Securities calculated in accordance with Section 6.7 of the Rights Agreement) then held by Investors (the “Required Majority”). 

B. WHEREAS, the undersigned stockholders of the Company constitute the Required Majority. 

C. WHEREAS, the Company and the Required Majority desire to amend the Rights Agreement. 

NOW, THEREFORE, the parties hereby agree as follows: 

1. Amendment to Section 1.13 of the Rights Agreement. Section 1.13 of the Agreement is deleted in its entirety and replaced
with the following: 
 “The term “Qualifying Public Offering” shall mean a firm-commitment underwritten public offering
pursuant to an effective registration statement under the Securities Act in which gross proceeds received by the Corporation shall be at least twenty million dollars ($20,000,000).” 

2. Full Force and Effect. Except as expressly modified by this Amendment, the terms of the Agreement shall remain in full force and
effect. 
 3. Governing Law. This Amendment shall be governed by and construed in accordance with the General Corporation Law of
California, without regard to its principles of conflict of laws. 
 4. Integration. This Amendment and the Rights Agreement and the
documents referred to herein and therein and the exhibits and schedules thereto, constitute the entire agreement and understanding of the parties with respect to the subject matter hereof, and supersede all prior understandings and agreements,
whether oral or written, between or among the parties hereto with respect to the specific subject matter hereof. 

 5. Counterparts. This Amendment may be executed in two or more counterparts, each of which
shall be deemed an original, but all of which together shall constitute one and the same instrument. 
 [REMAINDER OF PAGE INTENTIONALLY
LEFT BLANK] 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above
written. 
  

			
	COMPANY:
	
	ADESTO TECHNOLOGIES CORPORATION
		
	By:	 	 /s/ Narbeh Derhacobian

		 	Narbeh Derhacobian
		 	President and Chief Executive Officer
	
	 Address: 1250 Borregas Avenue

Sunnyvale, CA 94089

 SIGNATURE PAGE TO AMENDMENT NO. 1 OF THE INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above
written. 
  

			
	INVESTOR:
	
	Applied Ventures, LLC
		
	By:	 	 /s/ Hann-Ching Chao

		 	Hann-Ching Chao
		 	General Manager

 SIGNATURE PAGE TO AMENDMENT NO. 1 OF THE INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above
written. 
  

			
	INVESTOR:
	
	ARCH Venture Fund VI, L.P.
		
	By:	 	ARCH Venture Partners VI, L.P.
	Its:	 	General Partner
	By:	 	ARCH Venture Partners VI, LLC
	Its:	 	General Partner
		
	By:	 	 /s/ Keith Crandell

		 	Managing Director

 SIGNATURE PAGE TO AMENDMENT NO. 1 OF THE INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above
written. 
  

			
	INVESTOR:
	
	 ATA Ventures II, L.P., by its General Partner
ATA Management II, LLC

	 ATA Affiliates Fund II, L.P., by its General Partner
ATA Management II, LLC

	 ATA Investment Fund II, L.P., by its General Partner
ATA Management II, LLC

		
	By:	 	 /s/ T. Peter Thomas

		 	T. Peter Thomas, Managing Director

 SIGNATURE PAGE TO AMENDMENT NO. 1 OF THE INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above
written. 
  

			
	INVESTOR:
	
	Harris & Harris Group, Inc.
		
	By:	 	 /s/ Daniel B. Wolfe

		 	Daniel B. Wolfe
		 	General Counsel

 SIGNATURE PAGE TO AMENDMENT NO. 1 OF THE INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above
written. 
  

			
	INVESTOR:
	
	Microchip Technology Incorporated
		
	By:	 	 /s/ Steve Drehobl

	Name:	 	 Steve Drehobl

	Title:	 	 Vice President

 SIGNATURE PAGE TO AMENDMENT NO. 1 OF THE INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above
written. 
  

			
	INVESTOR:
	
	Serge Dassault
		
	By:	 	 /s/ Matt Boyle

	Name:	 	 Matt Boyle

	Title:	 	 Attorney In Fact

 SIGNATURE PAGE TO AMENDMENT NO. 1 OF THE INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above
written. 
  

			
	INVESTOR:
	
	Adams Street 2006 Direct Fund, L.P.
		
	By:	 	ASP 2006 Direct Management, LLC, its General Partner
	By:	 	Adams Street Partners, LLC, its Managing Member
		
	By:	 	 /s/ Michael R. Zappert

	Name:	 	 Michael R. Zappert

	Title:	 	Principal
	
	Adams Street 2007 Direct Fund, L.P.
		
	By:	 	ASP 2007 Direct Management, LLC, its General Partner
	By:	 	Adams Street Partners, LLC, its Managing Member
		
	By:	 	 /s/ Michael R. Zappert

	Name:	 	 Michael R. Zappert

	Title:	 	Principal

 SIGNATURE PAGE TO AMENDMENT NO. 1 OF THE INVESTORS’ RIGHTS AGREEMENT 

 IN WITNESS WHEREOF, the parties hereto have executed this Amendment as of the date first above
written. 
  

			
	        INVESTOR:
	
	Altera Corporation
		
	By:	 	 /s/ William Y. Hata

	Name:	 	 William Y. Hata

	Title:	 	 Senior Vice President

 SIGNATURE PAGE TO AMENDMENT NO. 1 OF THE INVESTORS’ RIGHTS AGREEMENT

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00250-of-00352.parquet"}]]